US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist
  • 0.580
  • -0.046-7.30%
Close Dec 20 16:00 ET
  • 0.608
  • +0.028+4.83%
Post 19:58 ET
34.29MMarket Cap-0.73P/E (TTM)

Elevation Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
21.14%13.23M
11.48%10.96M
-15.20%9.87M
-57.34%40.34M
-57.13%7.95M
-71.66%10.92M
-51.11%9.83M
-32.99%11.64M
195.04%94.55M
92.61%18.54M
Selling and administrative expenses
9.81%3.84M
15.95%4.41M
-11.23%3.86M
-5.86%14.9M
-19.33%3.26M
-16.54%3.5M
-0.21%3.81M
14.58%4.35M
87.34%15.83M
19.56%4.04M
-General and administrative expense
9.81%3.84M
15.95%4.41M
-11.23%3.86M
-5.86%14.9M
-19.33%3.26M
-16.54%3.5M
-0.21%3.81M
14.58%4.35M
87.34%15.83M
19.56%4.04M
Research and development costs
26.49%9.39M
8.66%6.55M
-17.57%6.01M
-67.69%25.43M
-67.65%4.69M
-78.39%7.42M
-63.01%6.03M
-46.28%7.29M
233.62%78.72M
132.07%14.5M
Operating profit
-21.14%-13.23M
-11.48%-10.96M
15.20%-9.87M
57.34%-40.34M
57.13%-7.95M
71.66%-10.92M
51.11%-9.83M
32.99%-11.64M
-195.04%-94.55M
-92.61%-18.54M
Net non-operating interest income expense
22.03%360K
289.30%513K
137.22%115K
40.00%-300K
-15K
295K
-271K
-309K
-500K
Non-operating interest income
----
----
----
290.00%3.9M
----
----
----
----
--1M
----
Non-operating interest expense
----
----
----
180.00%4.2M
----
----
----
----
--1.5M
----
Total other finance cost
-22.03%-360K
-289.30%-513K
-137.22%-115K
----
----
---295K
--271K
--309K
----
----
Other net income (expense)
81.55%-942K
-83,833.33%-5.04M
255.00%71K
-5,591.40%-5.11M
-185.71%-6K
900.00%20K
Special income (charges)
--0
--0
81.55%-942K
---5.11M
--0
--0
--0
---5.11M
--0
--0
-Less：Restructuring and merger&acquisition
--0
--0
--0
--5.11M
--0
--0
--0
--5.11M
--0
--0
-Less:Other special charges
----
----
--942K
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
----
1,283.33%71K
----
----
----
----
-185.71%-6K
900.00%20K
Income before tax
-21.12%-12.87M
-3.41%-10.45M
37.28%-10.7M
51.95%-45.67M
58.51%-7.89M
72.64%-10.63M
49.29%-10.11M
1.28%-17.05M
-196.69%-95.06M
-97.64%-19.02M
Income tax
9.09%12K
120.00%11K
120.00%11K
20.00%30K
-64.00%9K
11K
5K
5K
25K
25K
Net income
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
Net income continuous Operations
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
Minority interest income
Net income attributable to the parent company
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
Basic earnings per share
4.35%-0.22
50.00%-0.18
68.06%-0.23
67.24%-1.34
75.61%-0.2
86.23%-0.23
58.14%-0.36
2.70%-0.72
-54.92%-4.09
-97.76%-0.82
Diluted earnings per share
4.35%-0.22
50.00%-0.18
68.06%-0.23
67.24%-1.34
75.61%-0.2
86.23%-0.23
58.14%-0.36
2.70%-0.72
-54.92%-4.09
-97.76%-0.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 21.14%13.23M11.48%10.96M-15.20%9.87M-57.34%40.34M-57.13%7.95M-71.66%10.92M-51.11%9.83M-32.99%11.64M195.04%94.55M92.61%18.54M
Selling and administrative expenses 9.81%3.84M15.95%4.41M-11.23%3.86M-5.86%14.9M-19.33%3.26M-16.54%3.5M-0.21%3.81M14.58%4.35M87.34%15.83M19.56%4.04M
-General and administrative expense 9.81%3.84M15.95%4.41M-11.23%3.86M-5.86%14.9M-19.33%3.26M-16.54%3.5M-0.21%3.81M14.58%4.35M87.34%15.83M19.56%4.04M
Research and development costs 26.49%9.39M8.66%6.55M-17.57%6.01M-67.69%25.43M-67.65%4.69M-78.39%7.42M-63.01%6.03M-46.28%7.29M233.62%78.72M132.07%14.5M
Operating profit -21.14%-13.23M-11.48%-10.96M15.20%-9.87M57.34%-40.34M57.13%-7.95M71.66%-10.92M51.11%-9.83M32.99%-11.64M-195.04%-94.55M-92.61%-18.54M
Net non-operating interest income expense 22.03%360K289.30%513K137.22%115K40.00%-300K-15K295K-271K-309K-500K
Non-operating interest income ------------290.00%3.9M------------------1M----
Non-operating interest expense ------------180.00%4.2M------------------1.5M----
Total other finance cost -22.03%-360K-289.30%-513K-137.22%-115K-----------295K--271K--309K--------
Other net income (expense) 81.55%-942K-83,833.33%-5.04M255.00%71K-5,591.40%-5.11M-185.71%-6K900.00%20K
Special income (charges) --0--081.55%-942K---5.11M--0--0--0---5.11M--0--0
-Less：Restructuring and merger&acquisition --0--0--0--5.11M--0--0--0--5.11M--0--0
-Less:Other special charges ----------942K----------------------------
Other non- operating income (expenses) ------------1,283.33%71K-----------------185.71%-6K900.00%20K
Income before tax -21.12%-12.87M-3.41%-10.45M37.28%-10.7M51.95%-45.67M58.51%-7.89M72.64%-10.63M49.29%-10.11M1.28%-17.05M-196.69%-95.06M-97.64%-19.02M
Income tax 9.09%12K120.00%11K120.00%11K20.00%30K-64.00%9K11K5K5K25K25K
Net income -21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M
Net income continuous Operations -21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M
Minority interest income
Net income attributable to the parent company -21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M
Basic earnings per share 4.35%-0.2250.00%-0.1868.06%-0.2367.24%-1.3475.61%-0.286.23%-0.2358.14%-0.362.70%-0.72-54.92%-4.09-97.76%-0.82
Diluted earnings per share 4.35%-0.2250.00%-0.1868.06%-0.2367.24%-1.3475.61%-0.286.23%-0.2358.14%-0.362.70%-0.72-54.92%-4.09-97.76%-0.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List